Scan to Download
One powerful score. Smarter investment decisions.
NewAmsterdam Pharma Company NV
NAMS35.110USD
+1.210+3.57%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
33.900USD+33.900After-hours 12/22, 20:00 (ET)
3.97BMarket Cap
LossP/E TTM
NewAmsterdam Pharma Company NV
35.110
+1.210+3.57%
You can check out the annual or quarterly balance sheets of NewAmsterdam Pharma Company NV here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2022Q4
FY2022Q2
Total equity
Cash, cash equivalents and short-term investments
66.29%702.95M
71.62%739.16M
68.03%808.48M
145.03%834.19M
--422.73M
--430.71M
--481.15M
-27.21%340.45M
--467.73M
--93.79M
- Cash and cash equivalents
27.36%538.41M
30.92%563.86M
55.55%748.42M
126.68%771.74M
--422.73M
--430.71M
--481.15M
-27.21%340.45M
--467.73M
--93.79M
-Short-term investments
--164.54M
--175.30M
--60.06M
--62.45M
----
----
----
----
----
----
Receivables
293.49%20.25M
265.33%19.75M
-60.97%1.61M
1032.64%21.30M
--5.15M
--5.41M
--4.13M
-9.13%1.88M
--2.07M
--121.18M
-Accounts and notes receivable
----
----
----
----
----
----
----
----
----
--120.54M
-Other receivables
1117.68%20.04M
809.28%19.40M
-63.81%1.44M
2298.17%20.98M
--1.65M
--2.13M
--3.98M
--875.00K
--0.00
----
Prepaid expenses
-21.74%7.83M
18.40%10.94M
183.79%7.21M
77.53%7.92M
--10.00M
--9.24M
--2.54M
-45.48%4.46M
--8.18M
--12.44M
Other current assets
--1.31M
----
---171.00K
----
----
----
----
----
----
----
Total current assets
67.25%732.33M
72.86%769.85M
67.54%817.30M
148.97%863.41M
--437.87M
--445.35M
--487.82M
-27.45%346.79M
--477.98M
--227.41M
Non-current assets
Net Fixed Assets
-21.41%569.00K
-21.32%620.00K
336.69%607.00K
566.34%673.00K
--724.00K
--788.00K
--139.00K
-34.42%101.00K
--154.00K
--183.43K
Goodwill and other intangible assets
-25.97%439.00K
-13.28%470.00K
3.29%502.00K
214.12%534.00K
--593.00K
--542.00K
--486.00K
-18.27%170.00K
--208.00K
----
Long-term debt
----
----
----
----
----
----
----
----
----
--763.09K
Long-term prepaid expenses
----
----
----
-100.00%0.00
----
--8.00K
--16.00K
-77.56%35.00K
--156.00K
----
Other non-current assets
----
----
-100.00%0.00
-100.00%0.00
----
--8.00K
--16.00K
-77.56%35.00K
--156.00K
----
Total non-current assets
4007.74%54.10M
3282.81%45.26M
73.01%1.11M
294.44%1.21M
--1.32M
--1.34M
--641.00K
-40.93%306.00K
--518.00K
--946.52K
Total assets
79.06%786.43M
82.48%815.11M
67.55%818.41M
149.10%864.62M
--439.19M
--446.69M
--488.46M
-27.46%347.10M
--478.50M
--228.35M
Liabilities
Current liabilities
-Other payables
----
----
--0.00
----
----
----
----
----
----
----
Accrued expenses
-4.56%10.10M
-7.20%9.46M
-19.55%8.02M
19.39%13.61M
--10.58M
--10.19M
--9.97M
86.33%11.40M
--6.12M
----
Short-term debt and lease liabilities
----
----
----
----
----
----
----
-9.09%60.00K
--66.00K
--63.94K
-Short-term lease liabilities
----
----
----
----
----
----
----
-9.09%60.00K
--66.00K
--63.94K
Deferred liabilities
----
-100.00%0.00
-62.67%3.03M
-32.81%6.01M
--4.50M
--6.06M
--8.12M
-35.55%8.94M
--13.87M
--14.74M
Other current liabilities
----
-100.00%0.00
-62.67%3.03M
-32.81%6.01M
--4.50M
--6.06M
--8.12M
-35.55%8.94M
--13.87M
--14.74M
Total current liabilities
41.25%58.27M
-19.41%36.51M
-31.50%40.91M
114.28%106.92M
--41.26M
--45.31M
--59.73M
38.38%49.90M
--36.06M
--27.15M
Non-current liabilities
Long-term debt and lease liabilities
-68.05%85.00K
-68.60%103.00K
--137.00K
--202.00K
--266.00K
--328.00K
--0.00
--0.00
--0.00
--0.00
-Long-term lease liabilities
-68.05%85.00K
-68.60%103.00K
--137.00K
--202.00K
--266.00K
--328.00K
----
----
----
----
Deferred liabilities
----
----
----
-100.00%0.00
--0.00
--222.00K
--444.00K
-78.74%1.02M
--4.79M
--7.80M
Derivatives liabilities
----
----
----
-100.00%0.00
--18.81M
--13.39M
--16.49M
3.54%7.79M
--7.52M
----
Other non-current liabilities
----
----
-100.00%0.00
-100.00%0.00
--0.00
--222.00K
--444.00K
-78.74%1.02M
--4.79M
--7.80M
Total non-current liabilities
-99.55%85.00K
-99.26%103.00K
-99.19%137.00K
-97.71%202.00K
--19.07M
--13.94M
--16.93M
-28.83%8.81M
--12.37M
--7.89M
Total liabilities
-3.27%58.36M
-38.20%36.62M
-46.45%41.05M
82.47%107.12M
--60.33M
--59.25M
--76.66M
21.21%58.70M
--48.43M
--35.04M
Shareholders' equity
Common equity
67.80%1.41B
66.87%1.39B
67.58%1.37B
118.26%1.31B
--840.83M
--832.76M
--818.12M
6.23%600.94M
--565.68M
--171.44M
Retained earnings
-47.40%-687.47M
-36.85%-615.46M
-45.61%-598.10M
-76.22%-558.57M
---466.39M
---449.75M
---410.74M
-126.35%-316.97M
---140.04M
--20.79M
Capital reserves
68.41%1.40B
67.43%1.38B
68.16%1.36B
119.74%1.30B
--829.40M
--821.61M
--807.01M
6.33%590.77M
--555.63M
----
Gains losses not affecting retained earnings
4.93%4.64M
-2.15%4.33M
0.27%4.43M
1.02%4.47M
--4.42M
--4.42M
--4.42M
0.00%4.42M
--4.42M
----
Total equity
92.17%728.07M
100.93%778.50M
88.77%777.36M
162.66%757.50M
--378.86M
--387.44M
--411.80M
-32.94%288.39M
--430.07M
--193.31M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
FAQs
What is the balance sheet?
It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.
